{
	"法規性質": "命令",
	"英文法規名稱": "Fee-Charging Standards for Lot Release, Reference Materials, and Testing of Foods, Drugs and Cosmetics",
	"中文法規名稱": "食品藥物化粧品檢驗封緘及對照標準品供應收費標準",
	"法規網址": "https://law.moj.gov.tw/Eng/LawClass/LawAll.aspx?pcode=L0040094",
	"最新英文異動日期": "20240711",
	"附件": [
		{
			"檔案名稱": "Appendix.pdf",
			"下載網址": "https://law.moj.gov.tw/Eng/LawClass/LawGetFile.ashx?FileId=0000008657"
		}
	],
	"沿革內容": "1. Full text including 4 articles formulated and promulgated by the Executive Yuan, the Department of Health Order Shu-Shou-Shi No. 1001904420, on December 30, 2011.\r\n2. Text of article 1 amended by the Ministry of Health and Welfare Order Bu-Shou-Shi No. 1021950561, on October 2, 2013.\r\n3. Full text including 4 articles amended by the Ministry of Health and Welfare Order Bu-Shou-Shi No. 1041900335, on April 9, 2015.\r\n4. Text of article 2 related annex amended by the Ministry of Health and Welfare Order Bu-Shou-Shi No. 1051901465, on August 29, 2016.\r\n5. Text of article 2 related annex amended by the Ministry of Health and Welfare Order Wei-Shou-Shi No. 1081900724, on June 21, 2019.\r\n6. Text of article 1 and article 2 related annex amended by the Ministry of Health and Welfare Order Wei-Shou-Shi No. 1101900513, on March 26, 2021.\r\n7. Full text including 4 articles amended by the Ministry of Health and Welfare Order Wei-Shou-Shi No. 1131901181, on July 11, 2024.",
	"法規內容": [
		{
			"條號": "Article 1",
			"條文內容": "The standards are established in accordance with Article 58 of the Act Governing Food Safety and Sanitation, the second Paragraph of Article 104-2 of the Pharmaceutical Affairs Act, the second Paragraph of Article 76 of the Medical Devices Act, Article 30 of the Cosmetic Hygiene and Safety Act, and Article 10 of the Charges and Fees Act."
		},
		{
			"條號": "Article 2",
			"條文內容": "Contents of the standards are laid down in the Appendix."
		},
		{
			"條號": "Article 3",
			"條文內容": "On grounds for humane or relief purposes, biological preparations in the D numbering section of the Appendix that donated for use by international organizations, countries or pharmaceutical corporations can be exempted from all fees upon approvalby the central competent authorities."
		},
		{
			"條號": "Article 4",
			"條文內容": "The standards come into forceon the date of promulgation."
		}
	]
}